nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in tuberculosis control during the past decade
|
Naidoo, Kogieleum |
|
|
11 |
4 |
p. 311-313 |
artikel |
2 |
Clinical case definition of post-COVID-19 condition in children: a good start, but improvements are needed
|
Burki, Talha |
|
|
11 |
4 |
p. 314 |
artikel |
3 |
Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment
|
Rangaka, Molebogeng X |
|
|
11 |
4 |
p. 380-390 |
artikel |
4 |
Concerns regarding a suggested long COVID paradigm
|
Schwendinger, Fabian |
|
|
11 |
4 |
p. e33 |
artikel |
5 |
Concerns regarding a suggested long COVID paradigm
|
van der Palen, Jenny |
|
|
11 |
4 |
p. e34 |
artikel |
6 |
Concerns regarding a suggested long COVID paradigm
|
Cornish, Flora |
|
|
11 |
4 |
p. e35 |
artikel |
7 |
Concerns regarding a suggested long COVID paradigm – Authors' reply
|
Saunders, Chloe |
|
|
11 |
4 |
p. e36-e37 |
artikel |
8 |
Continuation of enteral nutrition until extubation in critically ill patients
|
Lobmeyr, Elisabeth |
|
|
11 |
4 |
p. 298-299 |
artikel |
9 |
Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial
|
Landais, Mickaël |
|
|
11 |
4 |
p. 319-328 |
artikel |
10 |
Correction to Lancet Respir Med 2023; published online Feb 3. https://doi.org/10.1016/S2213-2600(22)00491-X
|
|
|
|
11 |
4 |
p. e38 |
artikel |
11 |
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials
|
Mayer-Hamblett, Nicole |
|
|
11 |
4 |
p. 329-340 |
artikel |
12 |
Do chest x-ray-positive, sputum-negative individuals warrant more attention during tuberculosis screening?
|
Kendall, Emily A |
|
|
11 |
4 |
p. 304-306 |
artikel |
13 |
Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study
|
Solomon, Benjamin J |
|
|
11 |
4 |
p. 354-366 |
artikel |
14 |
First-line lorlatinib for advanced ALK-positive non-small-cell lung cancer
|
Lin, Jessica J |
|
|
11 |
4 |
p. 302-304 |
artikel |
15 |
Kogie Naidoo—when one condition leads to another
|
Kirby, Tony |
|
|
11 |
4 |
p. 315 |
artikel |
16 |
Philip Morris ejected from Canadian vaccine collaboration
|
Kirby, Tony |
|
|
11 |
4 |
p. e40 |
artikel |
17 |
Respiratory syncytial virus-induced disease in healthy infants: we need to offload this burden
|
Bem, Reinout A |
|
|
11 |
4 |
p. 301-302 |
artikel |
18 |
Sedative medications: an avoidable cause of asthma and COPD exacerbations?
|
Chalitsios, Christos V |
|
|
11 |
4 |
p. e31-e32 |
artikel |
19 |
SIMPLIFYing cystic fibrosis treatment in a post-modulator era
|
Yang, Connie |
|
|
11 |
4 |
p. 299-300 |
artikel |
20 |
Stalking the Great Killer: Arkansas's Long War on Tuberculosis
|
Burki, Talha |
|
|
11 |
4 |
p. 316 |
artikel |
21 |
Surviving sepsis with multiple serious complications
|
Kirby, Tony |
|
|
11 |
4 |
p. 317-318 |
artikel |
22 |
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study
|
Wildenbeest, Joanne G |
|
|
11 |
4 |
p. 341-353 |
artikel |
23 |
The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis
|
Sossen, Bianca |
|
|
11 |
4 |
p. 367-379 |
artikel |
24 |
Time to invest in tuberculosis research and disease control
|
The Lancet Respiratory Medicine, |
|
|
11 |
4 |
p. 297 |
artikel |
25 |
Tuberculosis and nutrition: what gets measured gets managed
|
McQuaid, C Finn |
|
|
11 |
4 |
p. 308-310 |
artikel |
26 |
US researchers call for FDA action to avoid another EVALI outbreak
|
Furlow, Bryant |
|
|
11 |
4 |
p. e39 |
artikel |
27 |
Vaccine anaphylaxis and Canadian public health policy
|
Abrams, Elissa M |
|
|
11 |
4 |
p. 306-308 |
artikel |